These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 2880704

  • 1. [Comparison of famotidine and ranitidine in duodenal ulcer].
    Rohner HG, Gugler R, Kimmig JM, Schönekäs H.
    Dtsch Med Wochenschr; 1987 Feb 27; 112(9):367-8. PubMed ID: 2880704
    [No Abstract] [Full Text] [Related]

  • 2. [Famotidine versus ranitidine in the acute treatment of duodenal ulcer. A multicenter comparative study in Germany].
    Simon B, Dammann HG, Jakob G, Miederer SE, Müller P, Ottenjann R, Paul F, Scholten T, Schütz E, Seifert E.
    Z Gastroenterol; 1985 Feb 27; 23(2):47-51. PubMed ID: 2865859
    [Abstract] [Full Text] [Related]

  • 3. Action of famotidine and ranitidine on prostaglandin E2 (PGE2) content of fundic and duodenal mucosa in duodenal ulcer patients.
    Lezoche E, Vagni V, D'Alessandro MD, Mariani P, Carlei F, Lomanto D, Nardovino M, Martelli A, Speranza V.
    Drugs Exp Clin Res; 1987 Feb 27; 13(10):655-8. PubMed ID: 2892658
    [Abstract] [Full Text] [Related]

  • 4. Treatment of active duodenal ulcers with famotidine. A double-blind comparison with ranitidine.
    Rohner HG, Gugler R.
    Am J Med; 1986 Oct 24; 81(4B):13-6. PubMed ID: 2877569
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of duodenal ulcer with famotidine].
    Schütze K, Hentschel E, Reichel W, Kerstan E.
    Wien Med Wochenschr; 1987 Sep 15; 137(17):409-11. PubMed ID: 2891224
    [Abstract] [Full Text] [Related]

  • 6. A multicenter, randomized, double-blind study comparing famotidine with ranitidine in the treatment of active duodenal ulcer disease.
    McCullough AJ.
    Am J Med; 1986 Oct 24; 81(4B):17-24. PubMed ID: 2877570
    [Abstract] [Full Text] [Related]

  • 7. Famotidine versus ranitidine for the short-term treatment of duodenal ulcer.
    Simon B, Dammann HG, Jakob G, Miederer SE, Müller P, Ottenjann R, Paul F, Scholten T, Schütz E, Seifert E.
    Digestion; 1985 Oct 24; 32 Suppl 1():32-7. PubMed ID: 2866134
    [Abstract] [Full Text] [Related]

  • 8. Famotidine (Pepcid).
    Med Lett Drugs Ther; 1987 Feb 13; 29(733):17-8. PubMed ID: 2880282
    [No Abstract] [Full Text] [Related]

  • 9. [Famotidine versus placebo in prevention of the recurrence of duodenal ulcer disease. A multicenter study in Germany, Austria and Italy].
    Baglioni A, Barbara L, Bianchi-Porro G, Blasi A, Canelli B, Cheli R, Dal Monte R, Dammann HG, Francavilla A, Hentschel E.
    Z Gastroenterol; 1985 Dec 13; 23(12):665-9. PubMed ID: 2868581
    [Abstract] [Full Text] [Related]

  • 10. Review of an extensive worldwide study of a new H2-receptor antagonist, famotidine, as compared to ranitidine in the treatment of acute duodenal ulcer.
    Bianchi Porro G, Dicenta C, Cook T, Humphries TJ.
    J Clin Gastroenterol; 1987 Dec 13; 9 Suppl 2():14-8. PubMed ID: 2887613
    [Abstract] [Full Text] [Related]

  • 11. Clinical review of histamine2 receptor antagonists.
    Lipsy RJ, Fennerty B, Fagan TC.
    Arch Intern Med; 1990 Apr 13; 150(4):745-51. PubMed ID: 1970232
    [Abstract] [Full Text] [Related]

  • 12. Famotidine in the treatment of duodenal ulcers resistant to other histamine H2-receptor antagonists.
    Chen PH, Wang TH, Wang CY, Chen CY, Cheng TC, Tsai YT, Siauw CP, Yang KC, Chen GH, Sung JL.
    J Int Med Res; 1989 Apr 13; 17 Suppl 1():25A-31A. PubMed ID: 2566541
    [Abstract] [Full Text] [Related]

  • 13. Famotidine in the USA: a review of efficacy studies.
    Gitnick G.
    J Int Med Res; 1989 Apr 13; 17 Suppl 1():17A-24A. PubMed ID: 2566539
    [Abstract] [Full Text] [Related]

  • 14. Famotidine in the short and long-term treatment of duodenal ulcer.
    Zaterka S, de Paula Castro L, Villalobos JJ, Massuda HK, Eisig JN, Dias Avelar C, Coelho LG, Bettarello A.
    Acta Gastroenterol Latinoam; 1988 Apr 13; 18(2):115-21. PubMed ID: 3075106
    [Abstract] [Full Text] [Related]

  • 15. H2-receptor antagonists and duodenal ulcer recurrence: analysis of efficacy and commentary on safety, costs, and patient selection.
    Freston JW.
    Am J Gastroenterol; 1987 Dec 13; 82(12):1242-9. PubMed ID: 2891294
    [Abstract] [Full Text] [Related]

  • 16. Comparison of famotidine with cimetidine and ranitidine.
    Berardi RR, Tankanow RM, Nostrant TT.
    Clin Pharm; 1988 Apr 13; 7(4):271-84. PubMed ID: 2896559
    [Abstract] [Full Text] [Related]

  • 17. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T, Lemaire M, Agostini H.
    Eur J Gastroenterol Hepatol; 1995 Jul 13; 7(7):661-5. PubMed ID: 8590162
    [Abstract] [Full Text] [Related]

  • 18. Famotidine in the treatment of gastric and duodenal ulceration: overview of clinical experience.
    Bianchi Porro G.
    Digestion; 1985 Jul 13; 32 Suppl 1():62-9. PubMed ID: 2866137
    [Abstract] [Full Text] [Related]

  • 19. [Famotidine. Pharmacologic and clinical profile of the new histamine H2 receptor antagonist].
    Müller P, Dammann HG, Simon B.
    Fortschr Med; 1986 Apr 17; 104(15):319-22. PubMed ID: 2872147
    [No Abstract] [Full Text] [Related]

  • 20. [I.v. famotidine versus i.v. ranitidine: intragastric pH behavior in surgical intensive care patients].
    Friedl W, Krier C, Dammann HG, Müller P, Simon B.
    Z Gastroenterol; 1985 Nov 17; 23(11):603-7. PubMed ID: 2868579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.